8:23 AM ET
8-K
Divestiture
Standard Biotools Divestiture to Archimed
Standard BioTools Inc. completed the sale of its Microfluidics business to healthcare investment firm ARCHIMED. The divested business will now operate as a standalone independent entity named Biomark Scientific, focusing on high-throughput genomic profiling and microfluidics technology.
- Counterparty
- ARCHIMED